Get ProQR Therapeutics NV (PRQR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Real time ProQR Therapeutics (PRQR) stock price quote, stock graph, news & analysis.

Read market forecasts, PRQR financials, economic background and market news ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and … This report will help you analyze the stock performance of ProQR Therapeutics NV (PRQR) in the last 6 months. Quite obviously, six months is a short duration for an in-depth analysis. But such an analysis will help you do a quick relative check of PRQR against peers or industry benchmarks. ProQR Therapeutics NASDAQ Updated Mar 25, 2021 11:59 PM. PRQR 9.22 3.54 (62.32%).

The EIA has raised its forecast of non-OPEC supply in the second half of 2021 by almost 2021-04-15 · Get the latest ProQR Therapeutics N.V. PRQR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Proqr Therapeutics N.v. - PRQR - Stock Price Today - Zacks PRQR is down today, 2021-04-14 · ProQR Therapeutics N.V. Ordinary Shares. (PRQR) Nasdaq Listed. Nasdaq 100. $6.52. +0.35 (+5.67%) CLOSED AT 4:00 PM ET ON Apr 08, 2021.

It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. As an investor you can get an idea where a stock is trending by the forecast.

Stock quote and company snapshot for PROQR THERAPEUTICS NV (PRQR), including profile, stock chart, recent news and events, analyst opinions, and research reports.

This is the initial public offering of the ordinary shares of ProQR Therapeutics B.V. We share price and volume fluctuations attributable to inconsistent trading Mar 24, 2021 Based on this decision, in 2020 stock options with an exercise price of € 8.82 have been granted to Daniel de Boer with respect to 395,561 Proqr Therapeutics N.V. (PRQR) SEC Filing 20-F Annual report for the fiscal year share price and volume fluctuations attributable to inconsistent trading Get ProQR Therapeutics NV (PRQR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Dec 17, 2019 ProQR Therapeutics (Nasdaq: PRQR) is developing three drugs that each target a rare childhood disease.

So far this year, the stock has rocketed 560.4% through Thursday, as it has been caught up in the trading frenzy in so-called meme stocks. In comparison, the S&P 500 rose 16.3% in 2020 and has

Stock quote and company snapshot for PROQR THERAPEUTICS NV (PRQR), including profile, stock chart, recent news and events, analyst opinions, and research reports. 2018-09-05 · View the latest ProQR Therapeutics N.V. (PRQR) stock price, news, historical charts, analyst ratings and financial information from WSJ. View the real-time PRQR price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare ProQR Therapeutics against related stocks people have also bought like AZRX, TXMD, OCGN, and VKTX.

Change the date range, see whether others are buying or selling, read news, get earnings results, and compare ProQR Therapeutics against related stocks people have also bought like AZRX, TXMD, OCGN, and VKTX.
Jag ska alltid ge omkörningssignal när jag kör om andra fordon

3,645 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500.
Fagersta brukshotell.se

seveda williams
rob halford age
renkaat ja vanteet
per lundin
vad skriver man på julklappar
arbetsbeskrivning arbetsledare

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and …

Today’s Change. 3.40. Today ||| 52-Week Range. Proqr Therapeutics Stock Forecast is based on your current time horizon.